Jon P. Stonehouse - 21 Mar 2023 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role: President & CEO, Director
Signature: /s/ Alane P. Barnes, by power of attorney
Issuer symbol: BCRX
Transactions as of: 21 Mar 2023
Net transactions value: +$99,997
Form type: 4
Filing time: 23 Mar 2023, 16:40:35 UTC
Previous filing: 02 Feb 2023
Next filing: 15 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BCRX	Common Stock	Options Exercise	$99,997	+31,055	+3.1%	$3.22	1,039,794	21 Mar 2023	Direct	F1
holding	BCRX	Common Stock						10,000	21 Mar 2023	By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust
holding	BCRX	Common Stock						10,000	21 Mar 2023	By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BCRX	Emp. Stock Option (Right to Buy)	Options Exercise	$0	-31,055	-9.2%	$0.000000	305,995	21 Mar 2023	Common Stock	31,055	$3.22	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person engaged in a non-market, cash exercise and hold transaction to purchase shares of issuer common stock underlying stock options that were originally granted to the reporting person on May 23, 2016. No sales of the issuer's common stock have occurred as part of this transaction.